Active Ingredient: TOFACITINIB CITRATE
Proprietary Name: XELJANZ XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 11MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N208246
Product Number: 001
Approval Date: Feb 23, 2016
Applicant Holder Full Name: PFIZER INC
Marketing Status:
Prescription
Patent and Exclusivity Information
